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world of health care big data characterized by massive volume,
complexity, and velocity. In particular, methods are needed that
can estimate models efﬁciently using very large datasets contain-
ing healthcare utilization data, clinical data, data from personal
devices, and many other sources. Although very large, such data-
sets can also be quite sparse (e.g., device data may only be available
for a small subset of individuals), which creates problems for
traditional regression models. Many machine learning methodsee front matter Copyright & 2015, International S
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Researchers using machine learning methods such as lasso or ridge
regression should assess these models using conventional speciﬁ-
cation tests.
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Outcomes Research (ISPOR). Published by Elsevier Inc.There is a worldwide explosion in the availability of data to
support outcomes research, health economics, and epidemiology.
Data availability is expanding along various dimensions simulta-
neously [1]. One is volume; for example, numerous initiatives are
amassing huge repositories of claims and electronic medical
record (EMR) data: Food and Drug Administration Mini-Sentinel,
the Patient-Centered Outcomes Research Institute Clinical Data
Research Networks, Patient-Centered Clinical Research Network,
Optum Labs, and many international examples [2–4]. There is
also the dimension of velocity—the speed with which users can
interact with the data. EMR data are often available almost in real
time. Moreover, the variety of data is expanding. Claims and EMR
data are increasingly being linked with health risk assessments,
sociodemographic data, and vital signs on a broad basis. And,
most recently, there is emerging data on genetic characteristics
of individuals, as well as data ﬂowing from devices such as FitBits
and biometric sensors. Such data are very rich, but they are
sparse—you have them only for certain people. This creates
challenges for traditional multivariate methods such as ordinary
least squares regression analysis because many observations are
lost due to missing data.
We have many good statistical methods for analyzing obser-
vational data. The sheer volume of data, along with their
characteristics, such as the unevenness of data completeness,
however, raises questions about the potential for using newmethods to analyze questions of treatment effectiveness, health
care value, strengths and weaknesses of alternative care organ-
ization models, policy interventions, and so on. In particular,
machine-learning methods, which have been extensively used in
the consumer retail sector (e.g., Amazon.com), may offer some
interesting alternatives to traditional statistical methods that
could potentially overcome many of the challenges posed by
“Big Data.”
The term “machine learning” refers to large family of math-
ematical and statistical methods that have historically been
focused on prediction [5]. We are often interested in prediction
in health care. What strain of ﬂu is likely to be prevalent in the
coming ﬂu season? How many vials of ﬂu vaccination must be
prepared to meet treatment demand? But prediction is not quite
the same thing as estimating treatment effects. For a physician,
the challenge is to isolate the effect of a treatment on patient
outcomes so that the correct treatment can be selected. Policy
evaluations face the same statistical challenges. Some machine-
learning methods have the ability to estimate treatment effects
and some do not. But the distinction between prediction and
treatment-effect estimation is almost completely absent in the
machine-learning literature.
In brief, the basic approach with all machine learning is to
segment the data into learning and validation data sets to
develop highly accurate classiﬁcation algorithms. Once theociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Fig. 1 – Good classiﬁers and bad classiﬁers. Reprinted with
permission of Robert Schapire [9].
Fig. 2 – Choosing the classiﬁcation rule. Reprinted with
permission of Robert Schapire [9].
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 1 3 7 – 1 4 0138algorithms have been developed, they are applied to the full data
set to do the prediction. The idea is that one should be able to
perform these classiﬁcations without human intervention, and
the methods should also be able to operate on very large data sets
and be very fast. In the machine-learning literature, this process
of using learning and training data sets to develop prediction
algorithms is known as K-fold cross-validation. The approach is
fairly straightforward. The idea is to take the initial data set and
randomly split it into several (typically 5 or 10) subsamples. For
each subsample that is held aside, the classiﬁcation algorithms
are built on each of the other remaining subsamples. Once the
algorithms have been built, each is used to predict the member-
ship prediction error that is associated with each one of the
subsamples. Finally, a sum of prediction errors is calculated over
all subsamples. Using this approach, one can evaluate different
machine-learning methods simultaneously and then compare
the average errors associated with each model to determine
which method performs the best. The process is completely
automated. The best algorithm is applied to the entire data set
—typically to do a prediction.
Machine-learning methods consist of a large number of
alternative methods including classiﬁcation trees, random for-
ests, neural networks, support vector machines, and lasso and
ridge regression to name a few. Classiﬁcation trees are a good
place to start because they illustrate the machine-learning
approach very intuitively and also extend directly to powerful
related methods such as random forests that are widely used for
predictive model development.
We begin with the notion of classiﬁers to predict group
membership. Figure 1 shows some examples of good and bad
classiﬁers. The box at the top of the ﬁgure is a good classiﬁer.
Assume that there are two types of observations—the pluses
and the minuses. It splits them almost perfectly except that
there is one mistake in the good box in which we have a
negative. By a very simple rule, just one line through the scatter
plot, the data have been classiﬁed. Down on the bottom row, we
have a variety of different cases. The ﬁrst one to the left has
split the data, but there are so few observations that we would
not have much conﬁdence in this particular algorithm and its
ability to perform equally well on another data set. In the
middle box, there are many errors. This algorithm is classifying
only about half of the cases properly, and we have a mix of
positives and negatives in each one of the groups. The ﬁnal
box is a classiﬁcation algorithm that is perfect in the sense
that it classiﬁes the positives and the negatives but it isextraordinarily complex. It is possible to create increasingly
precise classiﬁers by adding additional terms and nonlinear-
ities, powers, polynomials, and so forth. But there is no
guarantee that the rule is going to work on another data set.
Even if it does, complex rules are more difﬁcult to understand
and implement, so they are not as useful as simpler rules.
Figure 2 illustrates how classiﬁcation algorithms can be used
to form predictions. In this simple example, we have a collection
of characters from Batman. Some of these characters are good
guys and some are bad guys. Assume that we can classify the
good guys and the bad guys into groups. Batman, Robin, and
Alfred are all good guys. The Penguin, the Catwoman, and the
Joker are all bad guys. We have some measured characteristics
for all of them including their sex, whether they wear a mask,
whether they wear a cape or a tie, whether they have ears, and
whether they smoke. These observations constitute our training
data. Now, suppose that we have the same measured character-
istics for Bat Girl and the Riddler and we want to try to ﬁgure out
whether they are good or bad. Let us compare two different
classiﬁcation algorithms that could be used for categorizing them
as good or bad.
First, let us look at whether they wear a tie. Figure 2 shows
that we have the same inputs going into each one of two
classiﬁcation algorithms—whether the character wears a tie
and whether the character wears a cape. On the left, it is
apparent that the tie does not do a very good job of classifying.
We end up with Alfred and the Penguin both wearing ties, so we
have got a good guy and a bad guy in the Yes category. And
Batman and Robin do not wear ties, nor does Catwoman or the
Joker. So, we end up with two good guys and two bad guys in the
No category. Using the tie as a classiﬁer did not help at all. Now,
let us look at whether the characters wear a cape. Batman and
Robin both wear capes, so classifying them as good guys works
perfectly. In contrast, the Penguin, the Catwoman, and the Joker
do not wear capes, so that is correct as well. But, unfortunately,
Alfred is a good guy who does not wear a cape, so he is incorrectly
classiﬁed. Still, this is a pretty good classiﬁcation algorithm
because it correctly classiﬁed all but one of the characters in
the sample. This is what we are looking for—the ability to classify
as simply as possible with minimum error possible. On this basis,
the cape does a pretty good job. Normally, machine-learning
methods would build a very large tree and then prune it back.
One of the most powerful and popular machine-learning
methods is known as random forests. As the name implies,
random forest methods involve estimating a whole forest of
classiﬁcation trees. The process works like this: Randomly select
a subset m of predictor variables from an initial pool of, say, 1000
variables. The variable that provides the best split is used to do a
binary classiﬁcation on the ﬁrst node. At the next node, choose
Fig. 3 – Correlation versus causation. Reprinted with permission of Robert Schapire [9].
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process. Stop when all members of the sample have been
correctly classiﬁed. The ﬁnal model is based on the mode of the
classes output by the individual trees [6].
It seems that nearly every day, articles are published in
the popular press on using machine-learning methods and
big data methods focusing virtually exclusively on prediction. If
we are going to use machine-learning methods in the health
services ﬁeld for the purposes of estimating and evaluating
treatment effects, we must be thinking about how that problem
changes the way we think about the beneﬁts and challenges
associated with using machine learning. Machine learning is
composed of two broad categories of methods: classiﬁcation
and regression trees. Both sets of methods easily handle very,
very large data sets. They can include both qualitative and
quantitative predictor variables. And the classiﬁcation methods
are particularly adept at handling missing or sparse data. This is
very important—particularly if our interest is in prediction. To
estimate treatment effects, however, we need to use the methods
from the regression tree category. Here, we will face the tradi-
tional problems with missing variables arising in the usual
multivariate approaches, although machine-learning approaches
may still be attractive for other reasons that will become evident
shortly.
Figure 3 illustrates the difference between correlation and
causation. The green line is health care spending on science,
space, and technology over time. The red line is suicides byFig. 4 – Bigger samples do nohanging, strangulation, and suffocation. The two trends have a
99% correlation over time. This shows that anything that has a
strong trend over time will be highly correlated with anything
else that has a strong trend over time. That is a problem,
however, when you think about causal effects. It may be a great
predictor, but it is terrible from the standpoint of estimating
causal effects.
Some machine-learning approaches use regression-based
methods for prediction. For example, Lasso methods use a
correction factor to reduce the risk of overﬁtting [7]. Because
the Lasso method can force the coefﬁcients of some variables to
zero, it is useful for variable selection. Most importantly, because
Lasso regression involves the estimation of coef-
ﬁcients in a multivariate model, it is a short step to thinking
about the use of machine learning to obtain estimates of treat-
ment effects. Many researchers would feel uncomfortable letting
computers choose the speciﬁcation of the ﬁnal model. This is
understandable. Researchers, however, can certainly evaluate the
ﬁnal model for its theoretical or clinical plausibility, as well as
subject it to the usual battery of speciﬁcation tests. Moreover, the
risk of ending up with an implausible model can be broadly
managed by the selection of the set of starting variables from
which the model is constructed. Machine-learning methods
enable the starting set of variables to be much larger than is
normal practice in health services research, but it is not neces-
sary to completely throw out the concept of a theoretical or
clinical model. Finally, the K-fold cross-validation approach usedt protect against bias [8].
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and systematic version of the best practice of splitting one’s
sample into two—one for model development and the other for
ﬁnal model estimation.
Unfortunately, there is nothing magical about machine learn-
ing that protects against the usual challenges encountered in
observational data analysis. In particular, just because machine-
learning methods are operating on big data does not protect
against bias. Increasing sample size—for example, getting more
and more and more claims data—is not going to correct the
problem of bias if the data set is lacking in key clinical severity
measures such as cancer stage in a model of breast cancer
outcomes. This point is illustrated in Figure 4, which compares
instrumental variable estimates (that attempt to control for the
bias introduced by missing variables in treatment selection) to
ordinary least squares [8]. The example compares a small sample
and a bigger sample, and assumes the availability of a perfect
instrument that has no residual correlation with the error term of
the outcome equation. In such a case, instrumental variables are
an unbiased estimator of treatment effects. In contrast, ordinary
least squares, which is the red line, is somewhat biased but more
efﬁcient. In the larger sample size, the instrumental variables
estimator is much more efﬁcient than it was in the smaller
sample, but the larger sample has done nothing to reduce the
bias of ordinary least squares. In fact, the bias becomes more
apparent. So what ends up happening with more and more data
is that you just get biased estimates with smaller standard errors.
Thus, bigger data do not help with the bias problem, with one
exception—bigger samples can help us to make the data broader
by linking to variables that we are lacking.
For example, claims data are generally quite good for captur-
ing the breadth of experience of patients, their medical comor-
bidities, the drugs they take, their visits, and so on, but they are
not very good for measuring disease severity, cancer stage,
biomarkers, and so on. However, EMR data are much stronger
for capturing clinical detail but they can often be conﬁned to
particular sites such as hospitals and oncology clinics. In com-
parison with claims data, much of the knowledge about comor-
bidities may be missing. So, if you estimate a model with EMR
data alone, it is likely to be biased because it is missing important
information on comorbidities. If you estimate a model with
claims data alone, it is also likely to be biased because it lacks
important controls for clinical severity. Historically, this has been
one of the fundamental challenges with the analysis of observa-
tional data; we have been working with subsets of data that are
not complete enough to be able to enable the derivation of
reliable statistical inferences. The linkage of data sets should
help to address many of these issues and improve the ability of
machine-learning or traditional statistical methods to generate
more reliable models.Our ability to link data in a manner that protects patient
privacy has improved dramatically through the use of salting and
hashing methodologies. For example, if a provider group has
names, addresses, dates of birth, and social security numbers on
its patients, and a health plan has the same information on its
patients, it is no longer necessary to link individuals using these
ﬁelds of protected health information (PHI). Rather, each of the
entities holding the PHI can feed the PHI ﬁelds into a common
hashing algorithm that generates a one-way encryption that is
virtually impossible to reverse. Patients can then be linked on the
basis of their encrypted IDs without ever having to know the
identities of the individuals being linked.
In many ways, statistical models developed using machine-
learning methods such as K-fold cross-validation can be thought
of as extensions of more traditional health services research
methodologies from epidemiology and health econometrics. But
researchers will be reluctant to let computers do all the work of
choosing the ﬁnal model speciﬁcation. Partly, this is because
researchers tend to worry a lot about the data that they may be
missing and its implications for bias. Computers will simply
attempt to identify the best model given the data at hand. At a
minimum, the ﬁnal model estimated using a machine-learning
approach should be evaluated for its clinical or theoretical
plausibility and subjected to the standard battery of speciﬁcation
tests traditionally used by epidemiologists, econometricians, and
health services researchers.
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